InvestorsHub Logo
Followers 44
Posts 15214
Boards Moderated 0
Alias Born 09/16/2012

Re: kabunushi post# 690752

Saturday, 05/11/2024 10:17:11 PM

Saturday, May 11, 2024 10:17:11 PM

Post# of 694112
>>Clinicians estimate that the BRAF V600E mutation affects 15-20% of paediatric low-grade gliomas and between five and 10% of paediatric high-grade gliomas. (1,2).

"I’m able to just take tablets twice a day and go to the hospital every few months, rather than be in hospital to have chemotherapy. I’ve been able to start secondary school with my friends and go to pretty much all my lessons. I’ve also been able to be at home, rather than staying in hospital for treatment, and carry on my hobbies such as majorette.”

https://www.thebraintumourcharity.org/news/treatment-news/dabrafenib-and-trametinib-approved-to-treat-childhood-gliomas/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News